227 related articles for article (PubMed ID: 10556145)
21. Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis.
Winter RJ; George RJ; Deacock SJ; Shee CD; Geddes DM
Lancet; 1984 Jun; 1(8390):1338-9. PubMed ID: 6145035
[TBL] [Abstract][Full Text] [Related]
22. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
23. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
Ehsan Z; Clancy JP
Future Microbiol; 2015; 10(12):1901-12. PubMed ID: 26573178
[TBL] [Abstract][Full Text] [Related]
24. Aerosolized Antibiotics.
Restrepo MI; Keyt H; Reyes LF
Respir Care; 2015 Jun; 60(6):762-1; discussion 771-3. PubMed ID: 26070573
[TBL] [Abstract][Full Text] [Related]
25. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
26. Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis.
Florescu MC; Lyden E; Murphy PJ; Florescu DF; Fillaus J
Hemodial Int; 2012 Jul; 16(3):414-9. PubMed ID: 22469183
[TBL] [Abstract][Full Text] [Related]
27. Nebulised gentamicin-suitable for childhood bronchiectasis.
Twiss J; Byrnes C; Johnson R; Holland D
Int J Pharm; 2005 May; 295(1-2):113-9. PubMed ID: 15847996
[TBL] [Abstract][Full Text] [Related]
28. Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combination.
McShane PJ; Weers JG; Tarara TE; Haynes A; Durbha P; Miller DP; Mundry T; Operschall E; Elborn JS
Pulm Pharmacol Ther; 2018 Jun; 50():72-79. PubMed ID: 29621625
[TBL] [Abstract][Full Text] [Related]
29. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Greally P; Whitaker P; Peckham D
Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
[TBL] [Abstract][Full Text] [Related]
30. Concentration of gentamicin in bronchial secretions of children with cystic fibrosis of tracheostomy. (Comparison between the intramuscular route, the endotracheal instillation and aerosolization).
Baran D; Dachy A; Klastersky J
Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):336-41. PubMed ID: 809371
[TBL] [Abstract][Full Text] [Related]
31. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
Hodson ME; Wingfield HJ; Batten JC
Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
[TBL] [Abstract][Full Text] [Related]
32. Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
Palmer LB; Smaldone GC; Simon SR; O'Riordan TG; Cuccia A
Crit Care Med; 1998 Jan; 26(1):31-9. PubMed ID: 9428540
[TBL] [Abstract][Full Text] [Related]
33. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.
Orriols R; Roig J; Ferrer J; Sampol G; Rosell A; Ferrer A; Vallano A
Respir Med; 1999 Jul; 93(7):476-80. PubMed ID: 10464834
[TBL] [Abstract][Full Text] [Related]
34. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
[TBL] [Abstract][Full Text] [Related]
35. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients.
Boisson M; Mimoz O; Hadzic M; Marchand S; Adier C; Couet W; Grégoire N
J Antimicrob Chemother; 2018 Oct; 73(10):2830-2837. PubMed ID: 29947799
[TBL] [Abstract][Full Text] [Related]
37. Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.
Hoppentocht M; Akkerman OW; Hagedoorn P; Alffenaar JW; van der Werf TS; Kerstjens HA; Frijlink HW; de Boer AH
PLoS One; 2016; 11(3):e0149768. PubMed ID: 26959239
[TBL] [Abstract][Full Text] [Related]
38. [Inhaled colistin in cystic fibrosis].
Tamm M; Eich C; Frei R; Gilgen S; Breitenbücher A; Mordasini C
Schweiz Med Wochenschr; 2000 Sep; 130(39):1366-72. PubMed ID: 11059027
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis.
White L; Mirrani G; Grover M; Rollason J; Malin A; Suntharalingam J
Respir Med; 2012 Mar; 106(3):356-60. PubMed ID: 22204744
[TBL] [Abstract][Full Text] [Related]
40. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
